Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 9/20 | 0.46 |
| ▸ | CLCN2 | P51788 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14219812 | 0.88 | DHODH (0.51) | DHODHCLCN2LMNAGAAEGFR | |
| SCHEMBL14220139 | 0.88 | NPC1 (0.38) | DHODHCLCN2LMNAGAAEGFR | |
| SCHEMBL14219570 | 0.88 | DHODH (0.48) | DHODHCLCN2LMNAGAAEGFR | |
| SCHEMBL14219688 | 0.86 | LMNA (0.36) | DHODHCLCN2LMNAGAAMAP2K1 | |
| SCHEMBL14219608 | 0.83 | DHODH (0.54) | DHODHCLCN2LMNAGAAEGFR | |
| SCHEMBL14219814 | 0.81 | DHODH (0.43) | DHODHLMNAGAASORT1MAP2K1 | |
| SCHEMBL14219689 | 0.81 | DHODH (0.39) | DHODHCLCN2LMNAGAAEGFR | |
| SCHEMBL14219822 | 0.79 | DHODH (0.38) | DHODHLMNAGAAMAP2K1 | |
| SCHEMBL14219683 | 0.78 | LMNA (0.42) | DHODHCLCN2LMNAGAASORT1 | |
| SCHEMBL14222530 | 0.78 | NPC1 (0.40) | DHODHLMNAGAASORT1MAP2K1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1908751-A1 | N-hydroxy benzamides with antitumour activity | EOS S.p.A. (IT) | 2008-04-09 | — | — | EP | disclosed |